Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
ANTARES PHARMA, INC. | President and CEO, Director | Common Stock | 0 | $5.60 | May 24, 2022 | Direct | |
ANTARES PHARMA, INC. | President and CEO, Director | Stock Option (right to buy) | 0 | May 24, 2022 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
ATRS | ANTARES PHARMA, INC. | May 24, 2022 | 12 | -$16M | 4 | May 26, 2022 | President and CEO, Director |
ATRS | ANTARES PHARMA, INC. | Mar 3, 2022 | 2 | -$143K | 4 | Mar 4, 2022 | President & CEO, Director |
ATRS | ANTARES PHARMA, INC. | Feb 16, 2022 | 2 | -$125K | 4 | Feb 18, 2022 | President & CEO, Director |
ATRS | ANTARES PHARMA, INC. | Jun 10, 2021 | 4 | $659K | 4 | Jun 14, 2021 | President & CEO, Director |
ATRS | ANTARES PHARMA, INC. | Jun 8, 2021 | 1 | -$194K | 4 | Jun 10, 2021 | President & CEO, Director |